XML 21 R10.htm IDEA: XBRL DOCUMENT
v3.25.2

Basis of Presentation | 6 Months Ended
--- | ---
Jun. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Basis of Presentation | Basis of Presentation: In the opinion of management, the accompanying unaudited condensed consolidated financial statements of Albemarle Corporation and our wholly-owned, majority-owned and controlled subsidiaries (collectively, “Albemarle,” “we,” “us,” “our” or the “Company”) contain all adjustments necessary for a fair statement, in all material respects, of our consolidated balance sheets as of June 30, 2025 and December 31, 2024, our consolidated statements of income (loss), consolidated statements of comprehensive income (loss) and consolidated statements of changes in equity for the three-month and six-month periods ended June 30, 2025 and 2024 and our condensed consolidated statements of cash flows for the six-month periods ended June 30, 2025 and 2024. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the U.S. Securities and Exchange Commission (“SEC”) on February 12, 2025. The December 31, 2024 consolidated balance sheet data herein was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles (“GAAP”) in the United States (“U.S.”). The results of operations for the three-month and six-month periods ended June 30, 2025 are not necessarily indicative of the results to be expected for the full year. Revision of Previously Issued Financial Information During the second quarter of 2025, the Company identified an error in classification within its condensed consolidated statements of cash flows related to the proceeds from settlement and unrealized gains or losses from foreign currency forward contracts, affecting the cash flows from operating activities section, the cash flows from investing activities section and the Net effect of foreign exchange on cash and cash equivalents line of the statements of cash flows. The identified misclassification impacted our previously filed annual financial statements for the fiscal years ended December 31, 2024, 2023 and 2022, and quarterly financial statements for each of the fiscal quarters of fiscal year 2024 and the first fiscal quarter of fiscal year 2025 (collectively, the “Prior Financial Statements”). In addition, the Company made adjustments to correct for other previously identified immaterial errors. The Company assessed the materiality of the error in accordance with the SEC’s Staff Accounting Bulletin (“SAB”) No. 99 and SAB No. 108 and determined that the resulting misclassification was not material in any of the Prior Financial Statements, individually or in the aggregate. This revision had no impact on the consolidated balance sheets, consolidated statements of income (loss), consolidated statements of comprehensive income (loss), or consolidated statements of changes in equity of the Prior Financial Statements or notes thereto. A summary of the revisions to the Prior Financial Statements are shown below (in thousands):
| Three Months Ended March 31, 2025
| As Reported |  | Revision |  | As Revised
Noncurrent liability changes and other, net | $ | 357,146 |  |  | $ | 1,824 |  |  | $ | 358,970 |
Net cash provided by operating activities | 545,383 |  |  | 1,824 |  |  | 547,207 |
Proceeds from settlement of foreign currency forward contracts, net | $ | — |  |  | $ | 50,245 |  |  | $ | 50,245 |
Net cash used in investing activities | (179,303) |  |  | 50,245 |  |  | (129,058) |
Net effect of foreign exchange on cash and cash equivalents | $ | 80,207 |  |  | $ | (52,069) |  |  | $ | 28,138 |
| Year Ended December 31, 2024
| As Reported |  | Revision |  | As Revised
Decrease (increase) in inventories | $ | 1,560,450 |  |  | $ | (5,261) |  |  | $ | 1,555,189 |
Other, net | (107,104) |  |  | (8,931) |  |  | (116,035) |
Net cash provided by operating activities | 702,068 |  |  | (14,192) |  |  | 687,876 |
Capital expenditures | $ | (1,685,790) |  |  | $ | 5,261 |  |  | $ | (1,680,529) |
Payments for settlement of foreign currency forward contracts, net | — |  |  | (15,595) |  |  | (15,595) |
Net cash used in investing activities | (1,574,438) |  |  | (10,334) |  |  | (1,584,772) |
Net effect of foreign exchange on cash and cash equivalents | $ | (67,035) |  |  | $ | 24,526 |  |  | $ | (42,509) |
| Nine Months Ended September 30, 2024
| As Reported |  | Revision |  | As Revised
Working capital changes | $ | 823,194 |  |  | $ | 7,657 |  |  | $ | 830,851 |
Other, net | (17,415) |  |  | (16,796) |  |  | (34,211) |
Net cash provided by operating activities | 701,394 |  |  | (9,139) |  |  | 692,255 |
Capital expenditures | $ | (1,330,062) |  |  | $ | (7,657) |  |  | $ | (1,337,719) |
Payments for settlement of foreign currency forward contracts, net | — |  |  | (1,956) |  |  | (1,956) |
Net cash provided by (used in) investing activities | (1,246,628) |  |  | (9,613) |  |  | (1,256,241) |
Net effect of foreign exchange on cash and cash equivalents | $ | (14,763) |  |  | $ | 18,752 |  |  | $ | 3,989 |
| Six Months Ended June 30, 2024
| As Reported |  | Revision |  | As Revised
Working capital changes | $ | 460,937 |  |  | $ | 7,657 |  |  | $ | 468,594 |
Other, net | (118,711) |  |  | (3,355) |  |  | (122,066) |
Net cash provided by operating activities | 460,846 |  |  | 4,302 |  |  | 465,148 |
Capital expenditures | $ | (1,026,936) |  |  | $ | (7,657) |  |  | $ | (1,034,593) |
Proceeds from settlement of foreign currency forward contract, net | — |  |  | 12,991 |  |  | 12,991 |
Net cash provided by (used in) investing activities | (944,506) |  |  | 5,334 |  |  | (939,172) |
Net effect of foreign exchange on cash and cash equivalents | $ | (20,595) |  |  | $ | (9,636) |  |  | $ | (30,231) |
| Three Months Ended March 31, 2024
| As Reported |  | Revision |  | As Revised
Working capital changes | $ | (52,320) |  |  | $ | 3,720 |  |  | $ | (48,600) |
Other, net | (23,076) |  |  | (4,189) |  |  | (27,265) |
Net cash provided by operating activities | 97,954 |  |  | (469) |  |  | 97,485 |
Capital expenditures | $ | (579,322) |  |  | $ | (3,720) |  |  | $ | (583,042) |
Proceeds from settlement of foreign currency forward contracts, net | — |  |  | 18,224 |  |  | 18,224 |
Net cash provided by (used in) investing activities | (494,503) |  |  | 14,504 |  |  | (479,999) |
Net effect of foreign exchange on cash and cash equivalents | $ | 5,162 |  |  | $ | (14,035) |  |  | $ | (8,873) |
| Year Ended December 31, 2023
| As Reported |  | Revision |  | As Revised
Decrease (increase) in inventories | $ | (962,924) |  |  | $ | 5,261 |  |  | $ | (957,663) |
Other, net | (97,275) |  |  | (3,999) |  |  | (101,274) |
Net cash provided by operating activities | 1,325,321 |  |  | 1,262 |  |  | 1,326,583 |
Capital expenditures | $ | (2,149,281) |  |  | $ | (5,261) |  |  | $ | (2,154,542) |
Proceeds from settlement of foreign currency forward contracts, net | — |  |  | 221,849 |  |  | 221,849 |
Net cash used in investing activities | (2,781,160) |  |  | 216,588 |  |  | (2,564,572) |
Net effect of foreign exchange on cash and cash equivalents | $ | 222,686 |  |  | $ | (217,850) |  |  | $ | 4,836 |
| Year Ended December 31, 2022
| As Reported |  | Revision |  | As Revised
Other, net | $ | 91,270 |  |  | $ | 4,567 |  |  | $ | 95,837 |
Net cash provided by operating activities | 1,907,849 |  |  | 4,567 |  |  | 1,912,416 |
Payments for settlement of foreign currency forward contracts, net | $ | — |  |  | $ | (31,414) |  |  | $ | (31,414) |
Net cash used in investing activities | (1,422,649) |  |  | (31,414) |  |  | (1,454,063) |
Net effect of foreign exchange on cash and cash equivalents | $ | (37,217) |  |  | $ | 26,847 |  |  | $ | (10,370) |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 810 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/810/tableOfContent Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/205/tableOfContent + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration